The institute intends to perform SNP discovery, SNP-genotyping, and gene-expression studies on the system, Sequenom said. Specifically, researchers at the center plan to use the MassARRAY instrument to help them develop new genetic markers for cancer risk, diagnosis, disease progression, and therapeutic responsiveness.
Financial terms of the sale were not disclosed.
Sequenom began selling the desktop MassArray one year ago, according to Pharmacogenomics Reporter, GenomeWeb News' sister publication. The product, which is 73 percent smaller than the full-size system and costs around $285,000, takes 45 minutes to run a single plate, according to a company spokesperson. The standard MassArray platform takes around 25 minutes and costs around $500,000.